Disclosure of Interest/ Changes in Interest of Director/ Chief Executive Officer::Change in Interest of Substantial Shareholder

Issuer & Securities

Issuer/ Manager
PHARMESIS INTERNATIONAL LTD.
Securities
PHARMESIS INTERNATIONAL LTD. - SG1Q12920787 - P31
Stapled Security
No

Announcement Details

Announcement Title
Disclosure of Interest/ Changes in Interest of Director/ Chief Executive Officer
Date &Time of Broadcast
30-Jul-2014 19:28:27
Status
New
Announcement Sub Title
Change in Interest of Substantial Shareholder
Announcement Reference
SG140730OTHRQKNW
Submitted By (Co./ Ind. Name)
Mr Wu Xuedan
Designation
Executive Director / CEO
Description (Please provide a detailed description of the event in the box below - Refer to the Online help for the format)
Please refer to the attachments.

Additional Details

Person(s) giving notice
Director/Chief Executive Officer who may also be a substantial shareholder/unitholder (Form 1)
Date of receipt of notice by Listed Issuer
30/07/2014

Attachments

WU_Form1_Final.pdf
if you are unable to view the above file, please click the link below.
_WU_Form1_Final.pdf
Total size =139K